Religare Enterprises Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company reported a consolidated net profit after tax of ₹(1,343.68) lakhs for the quarter and ₹(2,305.65) lakhs for the half year. The Board also approved the financial results and discussed governance review findings, with no adverse financial impact identified.
Religare Enterprises Announces H1 FY27 Financial Results
Religare Enterprises Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company reported a consolidated net profit after tax of ₹(1,343.68) lakhs for the quarter ended September 30, 2026, compared to ₹(961.97) lakhs in the previous quarter and ₹(397.38) lakhs in the corresponding quarter of the previous year. For the half year ended September 30, 2026, the consolidated net profit after tax was ₹(2,305.65) lakhs, against ₹(1,012.19) lakhs in the same period last year.
Standalone Financial Performance
On a standalone basis, the company reported a net profit after tax of ₹(1,343.68) lakhs for the quarter ended September 30, 2026, and ₹(2,305.65) lakhs for the half year ended September 30, 2026. This contrasts with a net profit after tax of ₹(1,012.19) lakhs for the half year ended September 30, 2025.
Governance Review Update
The Board of Directors, at its meeting held on November 12, 2026, was updated on the governance review commissioned in March 2025. The review, conducted by M/s Trilegal, covered Religare Enterprises Limited and its subsidiaries for the period from April 01, 2018, to February 28, 2025. The final report indicated no implications or adverse financial impact on the company’s financial position, beyond what is already provided in the financial statements. The report identified areas for strengthening processes related to transaction initiation, assessment, execution, and approval, which the company plans to address in a phased manner. These areas include conflict identification and disclosure, business rationale and benefit assessment, vendor selection and comparative evaluation, monitoring of deliverables and payments, and expense and asset governance.
Key Board Approvals and Other Developments
The Board also approved the unaudited financial results for the quarter and half year ended September 30, 2026, subject to a limited review by the statutory auditors. Copies of the results and limited review reports are enclosed as Annexure-1, along with a media release as Annexure-2. The company continues to be barred from declaring dividends as per an RBI letter issued in December 2019. Several legal matters are ongoing, including preference share redemptions and disputes with various entities, which are sub-judice.
Additionally, the company has been actively managing its investment portfolio, including rights issues in its subsidiaries, Care Health Insurance Ltd (CHIL) and Religare Broking Limited. Religare Finvest Limited (RFL) has entered into One Time Settlement agreements with its lenders. The Reserve Bank of India (RBI) has also withdrawn restrictions imposed under a Corrective Action Plan (CAP) on RFL, allowing the company to hire senior management and restart its business operations.
Source: BSE
